Explaining Immunotherapy, PD-L1 and PD-1

Dr. Edward Garon explains the role of immunotherapy, PD-L1 and PD-1 in lung cancer. For more information visit www.lung.org/immunotherapy. Support for this educational program provided by Amgen, AstraZeneca, Blueprint Medicines, Bristol Myers Squibb, Genentech, Lilly Oncology, Merck, Novartis and Pfizer.